Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
08:00am, Tuesday, May 13, 2025
Mereo BioPharma Group PLC (NASDAQ: MREO) has recently released its financial results for the first quarter of 2025, revealing both challenges and opportunities for the biopharmaceutical company focused on developing innovative therapeutics for rare diseases.
Key points and statistics:
Net Loss: ...
07:02am, Tuesday, May 13, 2025
Energy Focus, Inc. Reports Improved Profitability Amid Revenue Decline and Customer Risks in Q1 2025
Energy Focus, Inc. (NASDAQ: EFOI) has reported its financial results for the first quarter of 2025. Here are key insights regarding its income statement:
Positive Aspects:
Gross Profit Increase: The gross profit for Q1 2025 was $0.2 million, representing 31.5% of net sales, an improvement from $...
07:02am, Tuesday, May 13, 2025
Regis Corporation (NYSE: RGS) Financial Summary
As of March 31, 2025, Regis Corporation reported a mix of positive and negative performance indicators in its income statement, reflecting both challenges and growth opportunities following its acquisition of Alline Salon Group.
Key Financial Highli...
07:02am, Tuesday, May 13, 2025
Company Overview
Peraso Inc. (NASDAQ: PRSO) specializes in manufacturing millimeter wave (mmWave) wireless technology products. The company engages in the development of integrated circuits and antenna modules and has recently transitioned its operations, formerly better known as MoSys, Inc.
Rece...
07:01am, Tuesday, May 13, 2025
22nd Century Group, Inc. (NYSE: XXII)
Financial Overview (Q1 2025)
Net Revenues: $5,956,000, a decrease of 7.9% from $6,469,000 in Q1 2024.
Gross Profit: Loss of $609,000 vs. $1,129,000 in Q1 2024 (improvement).
Operating Expenses: $1,961,000, down from $3,305,000 in the prior year, largely due ...
07:01am, Tuesday, May 13, 2025
AsiaFIN Holdings Corp. (PINK: ASFH) is navigating a challenging financial landscape as reflected in its latest quarterly report for the period ending March 31, 2025.
Key Financial Statistics:
Revenue: $621,179 (increased from $519,752 in Q1 2024, +19.5%)
Cost of Revenue: $628,092 (increased from...
07:00am, Tuesday, May 13, 2025
Leap Therapeutics, Inc. (NASDAQ: LPTX) reported its financial progress for the quarter ending March 31, 2025. The company is focused on developing biomarker-targeted antibody therapies aimed at treating cancer.
Positive Aspects:
Research and development expenses increased by $1.6 million, driven...
06:03pm, Monday, May 12, 2025
Ascend Wellness Holdings, Inc. (PINK: AAWH) has released its financial results for the first quarter ending March 31, 2025.
Overall Performance:
Revenue decreased to $127.997 million, down from $142.410 million in Q1 2024, reflecting a 10% decline.
Net loss increased to $19.258 million compared ...
06:03pm, Monday, May 12, 2025
Bally’s Corporation (NYSE: BALY)
Bally's Corporation has recently undergone significant changes following the acquisition of The Queen Casino & Entertainment, Inc., which was finalized on February 7, 2025. This merger reflects a strategic effort to expand their market presence.
Current Financial ...
06:02pm, Monday, May 12, 2025
Company Overview: Hertz Global Holdings, Inc. (NYSE: HTZ) is engaged in the global vehicle rental business under several brands, including Hertz, Dollar, and Thrifty. The company operates through various subsidiaries and focuses on enhancing customer experiences while managing operational efficie...
06:02pm, Monday, May 12, 2025
Company Overview: InMed Pharmaceuticals Inc. (NASDAQ: INM) focuses on developing therapeutic products for serious diseases, particularly through rare cannabinoids and novel cannabinoid analogs. The company has been actively pursuing diverse projects concentrated on unmet medical needs and manufac...
06:01pm, Monday, May 12, 2025
Investors Title Company (NASDAQ: ITIC) has released its financial results for the first quarter of 2025, providing insight into its performance and the overall health of its operations.
Key Financial Highlights:
Total Revenues: $56.57 million, up from $53.46 million in Q1 2024.
Net Premiums Writ...
06:01pm, Monday, May 12, 2025
Company Overview: MicroVision, Inc. (NASDAQ: MVIS) is focused on laser beam scanning (LBS) technology for various applications, including Lidar sensors for automotive and industrial use. The company is striving to build partnerships and expand its product offerings, especially in the autonomous d...
06:00pm, Monday, May 12, 2025
Company Overview: Scienture Holdings, Inc. (NASDAQ: SCNX), formerly known as TRxADE Health, Inc., underwent significant operational changes during Q1 2025. The company has shifted focus towards its branding and specialty pharmaceutical ventures, particularly through its subsidiary Scienture, LLC....
06:00pm, Monday, May 12, 2025
Company OverviewMineralys Therapeutics, Inc. (NASDAQ: MLYS) is a clinical-stage biopharmaceutical company focused on developing treatments for diseases driven by dysregulated aldosterone. The company is advancing its lead product candidate, lorundrostat, for hypertension and related conditions. A...